Other languages TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
2.14 ^USD	+2.39%		+2.39%	-4.89%

May. 10	TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 29	TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29
TherapeuticsMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
TherapeuticsMD, Inc. Announces Evaluation of Strategic Alternatives	Nov. 13
ETF: profiteren van de vergrijzing	Nov. 02
TherapeuticsMD, Inc. Announces Executive Changes	23-08-18
TherapeuticsMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Pas de problème, la Fed est là	23-05-16
En Direct des Marchés : Stellantis, TotalEnergies, Bouygues, Edenred, Microsoft, Amgen, KBC, Sonova...	23-05-16
TherapeuticsMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
TherapeuticsMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-07
TherapeuticsMD, Inc. Auditor Raises 'Going Concern' Doubt	23-04-06
TherapeuticsMd, Inc. Announces Chief Executive Officer Changes	23-01-06
TherapeuticsMd, Inc. Announces Executive Changes	23-01-06
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday	23-01-03
TherapeuticsMD Completes Product License Deal to Mayne Pharma Group	23-01-03
Mayne Pharma Group Limited Completes TherapeuticsMD, Inc. Product Licensing Transaction	23-01-02
Mayne Pharma, Inc. completed the acquisition of Certain Assets of TherapeuticsMD, Inc.	22-12-29
TherapeuticsMD Agrees to Grant Product License to Mayne Pharma Group; Shares Surge Pre-Bell	22-12-05
Mayne Pharma Group Signs Exclusive License Deal for Women's Health Products, Prenatal Vitamins; Shares Slump 13%	22-12-04

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages TherapeuticsMD, Inc.

Equities

TXMD

US88338N2062

Other languages

Filters